OrganonOGN +0.22%71 Days Inventory is 187.28 as of Mar. 2026, which is 10% above its 10-year median of 170.87. GuruFocus rates OGN with a GF Score™ of 71/100 and a GF Value™ of $14.55 (Fairly Valued). The stock has 10 warning signs investors should review. Among 919 Drug Manufacturers companies, Organon ranks worse than 56.04% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Organon's Average Total Inventories for the
three
months ended in Mar. 2026 was $1,390 Mil. Organon's Cost of Goods Sold for the
three
months ended in Mar. 2026 was $677 Mil.
Hence, Organon's Days Inventory for the
three
months ended in Mar. 2026 was 187.28.
The historical rank and industry rank for Organon's Days Inventory or its related term are showing as below:
OGN'
s Days Inventory Range Over the Past 10 Years
Min: 140.05 Med: 170.87 Max: 178.97
Current: 177.81
During the past 8 years, Organon's highest Days Inventory was 178.97. The lowest was 140.05. And the median was 170.87.
OGN's Days Inventory is ranked worse than 56.04% of 919
companies
in the Drug Manufacturers industry
Industry Median: 162.83
vs OGN: 177.81
Organon's Days Inventory
increased
from Mar. 2025 (182.16) to Mar. 2026 (187.28).
It might indicate that Organon's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Organon's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.49.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Organon's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.95.
Organon (NYSE:OGN) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Organon's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Organon's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Organon Days Inventory Related Terms
Organon Days Inventory Historical Data
* Premium members only.
The historical data trend for Organon's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OGN vs AMRN, SCLX, MIRA: Days Inventory Comparison
For the Drug Manufacturers - General subindustry, Organon's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Organon Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Organon's Days Inventory distribution charts can be found below:
* The bar in red indicates where Organon's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Organon (OGN) has a Days Inventory of 187.28 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Organon and its competitors. This is 10% above median its historical median of 170.87. Over the past decade, Organon's Days Inventory has ranged from 140.05 to 178.97. According to the industry distribution chart, Organon ranks #515 out of 919 companies in the Drug Manufacturers industry, placing it in the top 56%.
Is Organon's Days Inventory too high?
Organon's current Days Inventory of 187.28 is 10% above median its 10-year median of 170.87. Over the past 10 years, this metric has ranged from a low of 140.05 to a high of 178.97. The Drug Manufacturers industry median Days Inventory is 162.83. Organon's value of 187.28 is 15% above this industry median. Based on the distribution chart, Organon ranks #515 out of 919 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Organon has a GF Score™ of 71/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Organon's Days Inventory compare to AMRN and SCLX?
According to the Drug Manufacturers industry distribution chart, Organon ranks #515 out of 919 companies for Days Inventory. This places Organon in the lower half of its industry. The industry median Days Inventory is 162.83. Organon's value of 187.28 is 15% above this benchmark. Historically, Organon's own Days Inventory has ranged from 140.05 to 178.97 over the past decade. While the company's 10-year median is 170.87 vs. the industry median of 162.83, Organon has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 162.83, based on 919 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Organon's current Days Inventory of 187.28 is 15% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Organon and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 162.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Organon's current Days Inventory is 187.28, which is 10% above median its own 10-year median of 170.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Organon stock overvalued right now?
Based on GuruFocus' analysis, Organon (OGN) is currently considered Fairly Valued. The stock's GF Value™ is $14.55, compared to a current price of $13.50 — trading 7.2% below its estimated fair value. The current Days Inventory is 187.28, which is 10% above median its 10-year median of 170.87 and 15% above the Drug Manufacturers industry median of 162.83. Organon's overall GF Score™ is 71/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Organon (OGN), the current Days Inventory is 187.28 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Organon (OGN) Overvalued in 2026?
Based on GuruFocus' analysis, Organon stock appears to be undervalued.
The current stock price of $13.50 is trading 7.2% below its estimated GF Value™ of $14.55.
GuruFocus considers Organon to be Fairly Valued.
Key valuation signals for OGN:
Days Inventory: 187.28 (10% above median its 10-year median of 170.87)
GF Value™: $14.55 vs. price of $13.50 (7.2% below fair value)
Industry Position: 15% above the Drug Manufacturers median (#515 of 919)
No single metric tells the full story. See the OGN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.
71GF Score
Get the complete analysis for OGN
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OGN has been successfully added to your 
